TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
OABI

OmniAb Inc.

Healthcare · Biotechnology

4.60$ -3.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

OmniAb Inc. (OABI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 290 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OABI
Line item Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 295 0.4 0.6 283 304 237 307 238 421 413 405 392 375 353 337 332 326 306 296 310 301 294 290
– 17 – 0.0 5.8 23 1.1 13 0.4 125 121 116 107 95 77 67 67 68 54 48 66 65 65 66
– – – 0.0 0.4 -14 0.4 0.2 0.0 33 23 21 21 16 19 21 27 28 11 18 29 26 29 24
– – – 0.0 0.4 -14 0.4 0.2 0.0 88 114 103 97 87 69 57 59 59 44 42 60 54 49 52
– 16 – – 4.8 21 – 8.2 4.7 30 1.8 8.6 6.1 3.8 4.0 6.9 3.5 5.3 6.5 2.7 3.1 7.4 13 10
– – – – -4.8 14 – 0.9 -4.7 – – 0.0 0.0 0.0 0.0 – – – – – 0.4 – 0.9 1.0
– – – – 14 20 – 38 41 41 19 19 – – – – – – – – – – – –
– 84 – – 84 84 – 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84
– 187 – – 178 176 – 169 166 167 164 162 159 155 152 148 144 138 135 132 128 125 119 116
– 60 0.4 0.6 55 70 14 80 14 80 72 71 67 61 51 43 40 38 33 34 32 34 31 30
– 14 0.4 0.6 14 21 5.5 24 10 26 22 24 25 23 18 14 14 15 11 13 13 16 14 14
– 0.6 0.1 0.2 0.7 0.6 0.5 2.0 0.8 1.8 2.4 3.4 3.5 3.5 3.5 3.6 3.8 3.8 3.8 3.8 3.9 3.9 3.9 4.0
– 0.5 – – 1.8 2.9 – 7.4 6.3 3.0 2.5 2.4 2.5 4.4 3.6 2.8 2.2 2.3 1.9 2.0 1.9 1.9 1.7 2.1
– 236 0.0 0.0 228 234 223 227 223 341 341 334 325 315 301 294 292 288 274 262 277 267 263 260
– – 0.0 0.0 -6.9 -7.6 -12 -14 -14 11 5.2 -9.6 -25 -39 -58 -72 -88 -101 -120 -135 -152 -166 -174 -180
115 115 115 115 115 83 115 115 115 94 99 99 100 100 101 101 102 105 106 106 115 128 128 129

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?